Liquid light guide catheter having biocompatible liquid light guide medium

Patent metadata

Field	Value
Publication number	US-9848952-B2
Application number	US-92348807-A
Country	US
Kind code	B2
Filing date	Oct 24, 2007
Priority date	Oct 24, 2007
Publication date	Dec 26, 2017
Grant date	Dec 26, 2017

Abstract

A catheter system to ablate target matter within a mammalian body using light energy is described. The system may include an open-ended catheter tip through which a liquid light guide medium flows to the target matter, where at least a portion of the liquid light guide medium exiting the catheter tip creates a fluid optical channel to transmit the light energy from the catheter tip to the target matter. The system may also include a catheter lumen whose distal end includes the open-ended catheter tip, a light source to generate the light energy, and a liquid light guide medium source fluidly coupled to the catheter lumen. The liquid light guide medium source may include a reservoir of the liquid light guide medium that includes a magnesium chloride solution or a lactated Ringer's solution.

First claim

What is claimed is:

1. A method of delivering light energy to target matter in a mammalian body, the method comprising:
positioning an open-ended catheter to face the target matter inside the mammalian body;
pumping a liquid having an ion concentration that is isotonic with mammalian blood from a reservoir and through the open-ended catheter to the target matter, and creating a liquid optical channel between the catheter and the target matter with the liquid, the liquid optical channel surrounded by blood in the body to transmit the light energy from the catheter to the target matter through the liquid optical channel;
activating a light source to generate the light energy; and
transmitting the light energy through the liquid optical channel to the target matter by total internal reflection and ablating the target matter with the light energy, wherein the light energy has a wavelength in a range of 305-310 nm, the liquid includes magnesium and chloride ions and has an index of refraction in a range of 1.33-1.42 for the wavelength, and the index of refraction of the liquid is at least 5% higher than an index of refraction of the catheter and is higher than an index of refraction of the blood in the body.

2. The method of claim 1 , wherein the liquid comprises a magnesium chloride solution and has an index of refraction between 1.33 and 1.42 for 308 nm light energy.

3. The method of claim 2 , wherein the magnesium chloride solution comprises magnesium chloride hexahydrate and has an index of refraction between 1.33 and 1.42 for 308 nm light energy.

4. The method of claim 1 , wherein the liquid medium comprises one of aqueous magnesium chloride solutions, pure magnesium chloride solutions, solutions of anhydrous magnesium chloride, and solutions of hydrated magnesium chloride.

5. The method of claim 4 , wherein the method further comprises forming a cavity in remaining target matter after the ablation, where the cavity provides a cladding surface to extend the liquid optical channel into the remaining target matter and wherein the light.

6. The method of claim 1 , wherein the light source is a XeCl Excimer laser and the light energy has a wavelength of 308 nm.

7. The method of claim 1 , wherein the method further comprises exclusively transmitting the light energy through the liquid from the light source to the open-ended catheter.

Assignees

• Khanna Krishn
• Splinter Robert
• Spectranetics Corp

Inventors

• Khanna Krishn
• Splinter Robert

Classifications

• A61B2018/2261

  with scattering, diffusion or dispersion of light · CPC title

• A61B2018/206

  the laser light passing along a liquid-filled conduit · CPC title

• A61B18/20

  using laser · CPC title

• A61B2018/00577

  Ablation · CPC title

• G02B6/032

  with non solid core or cladding {(G02B6/02295 takes precedence)} · CPC title